Prospective Evaluation of Bleeding Risk of Anticoagulant and Anti-platelet Therapy

The Perioperative Management of Anti-thrombotic Drug Registry

NCT03695159 ·Status: COMPLETED

Comparative Study Between Thrombosis Prophylaxis Protocols

NCT00713973 ·Status: COMPLETED

Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study

NCT03988231 ·Status: WITHDRAWN ·Phase: PHASE4

STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis

NCT05255003 ·Status: RECRUITING ·Phase: PHASE4

Anti-Xa Level With Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19 and Non-COVID-19 Patients

NCT05926518 ·Status: COMPLETED

Risk Factors for Venous Thromboembolism in the Community

NCT00011180 ·Status: COMPLETED

Apixaban in Patients Who Undergo CIED Procedure- Randomized Pilot Study

NCT02450682 ·Status: WITHDRAWN ·Phase: PHASE2

Bridging Therapy in Patients at High Risk for Stent Thrombosis Undergoing Surgery

NCT00653601 ·Status: UNKNOWN

Microvesicle Production After Acute Trauma and Its Clinical Impact on Venothromboembolism

NCT01264458 ·Status: COMPLETED

Evaluation of Wound Drainage After Knee or Hip Arthroplasty

NCT02054936 ·Status: WITHDRAWN ·Phase: PHASE4

AntiCoagulation Tracking InterVention and Evaluation

NCT04059965 ·Status: WITHDRAWN ·Phase: NA

A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill Patients

NCT02213978 ·Status: COMPLETED

Pharmacogenomics of Heparin-Induced Thrombocytopenia

NCT02717039 ·Status: RECRUITING

Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients

NCT03251963 ·Status: COMPLETED ·Phase: PHASE2

Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism

NCT00788736 ·Status: COMPLETED

Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome

NCT02295475 ·Status: COMPLETED ·Phase: PHASE4

inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT

NCT06581965 ·Status: RECRUITING ·Phase: PHASE4

A Study to Compare the Risk of a Major Bleeding in Participants Who Received Blood Thinning Medications Following a Blood Clot

NCT03521908 ·Status: COMPLETED

Effect of Anticoagulant and Antiplatelet Drug Intervention on Postoperative Major Adverse Events in Patients with PAD：Phase II

NCT06850207 ·Status: NOT_YET_RECRUITING

Prevention of Venous Thrombosis After Permanent Transvenous Leads Implantation

NCT00621491 ·Status: COMPLETED ·Phase: NA

Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin

NCT02970032 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Anti-Xa Guided Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism Following Traumatic Injury: a Multicentre Pilot Randomized Trial

NCT06662253 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3

Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Comparison Between Rivaroxaban and Enoxaparin

NCT03299296 ·Status: UNKNOWN ·Phase: PHASE3

Comparative Effectiveness and Safety Between Warfarin and Dabigatran

NCT03254134 ·Status: COMPLETED

Prolonged Anticoagulation Therapy on the Prognosis of Patients With Left Ventricular Thrombosis

NCT06209892 ·Status: NOT_YET_RECRUITING ·Phase: NA